Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E. Seah
Institution:
J Ints Bio (South Korea)
Observed institutions:
National University Hospital,
National University Health System,
J Ints Bio (South Korea)
ORCID:
0000-0002-6570-029X
Observed ORCID:
0000-0002-6570-029X
OpenAlex ID:
A5072426474
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
2011
·
W.P. Yong
, B.C. Goh
, et al.
·
Annals of Oncology
·
38
Phase I study of SB939 three times weekly for 3 weeks every 4 weeks in patients with advanced solid malignancies
2009
·
W. Yong
, B. Goh
, et al.
·
Journal of Clinical Oncology
·
10
413 POSTER A phase I dose escalation study of oral SB939 when administered thrice weekly (every other day) for 3 weeks in a 4-week cycle in patients with advanced solid malignancies
2008
·
W.P. Yong
, B.C. Goh
, et al.
·
European Journal of Cancer Supplements
·
4
P3.12D.02 Phase 1/2 Clinical Trial of JIN-A02, a 4th Generation EGFR-TKI in EGFR Mutated Advanced/metastatic Non-Small Cell Lung Cancer (NSCLC)
2024
·
S.M. Lim
, B.C. Cho
, et al.
·
Journal of Thoracic Oncology
·
3
PDF
70 (PB058): Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-tyrosine kinase inhibitor (TKI), in patients with 3rd generation EGFR-TKI resistance in EGFR mutated advanced/metastatic non-small cell lung cancer (NSCLC)
2024
·
S.M. Lim
, B.C. Cho
, et al.
·
European Journal of Cancer
·
1
597TiP A phase I/II study to evaluate the safety and anti-tumor activity of JIN-A02 in patients with EGFR TKI-refractory, EGFR-mutant advanced NSCLC
2023
·
S.M. Lim
, B.C. Cho
, et al.
·
Annals of Oncology
·
1
PDF
P2.09-09 A Phase 1, 2 Study to Evaluate the Safety and Anti-tumor Activity of JIN-A02 in Patients with EGFR Mutant Advanced NSCLC
2023
·
S.M. Lim
, B.C. Cho
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
P3.18.57 Phase 1/2 Clinical Trial of JIN-A02, a 4th Generation EGFR-TKI in EGFR Mutant Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
2025
·
S-M. Lim
, B.C. Cho
, et al.
·
Journal of Thoracic Oncology
Show more works
View as search
Works count:
8
Citation count:
58
H-index:
3
I10-index:
2
Year
Topic
Type